Cincinnati Attorney News
The Lyon Firm News focuses on important legal and medical safety issues from the point of view of a trial lawyer. The Lyon Firm News is designed to provide summaries and commentary on the most important issues affecting the current cases found under Featured Cases. We also provide updates on recent settlements, both inside and outside the Firm, that are considered newsworthy.
Featured Cincinnati Cincinnati Attorney News Articles
FDA REVIEWING SAFETY CONCERNS OF INFUSE BONE GRAFT
Thomas & Lyon, LLC is actively investigating the safety of InFuse Bone Graft/ LT-Cage (Lumbar Tapered Fusions Device)("InFuse Bone Graft'). The investigation includes a variety of injury claims including but limited to (1) ectopic bone growth, (2) cancer, and (3) male infertility. The investigation also includes the allegations of "off-label" marketing and the allegations of improper financial arrangements with treating physicians that have been reported in the national media1 as well as in Cincinnati, Ohio and Louisville, Kentucky.
FDA REVIEWING SAFETY OF SURGICAL SCRUB TRICLOSAN
The FDA will continue its investigation into the safety of Triclosan, a chemical found in many houshold items. The FDA opened its investigation in April 2010, and announced that it will extend its assessment. Currently, the evidence remains insufficient to raise safety fears; however, the FDA also noted that there is no evidence of an added benefit than regular soap and water in the average household environment.
New Study Links Autism to SSRI Use
The New York Times reported that two new studies were published linking pre-natal exposure to S.S.R.Is and other enviornmental factors to an increase risk of autism.
Court Takes A Strong Step Toward More Equity in Medicare Set Asides
In a positive step toward curbing government over-reaching in personal injury actions, the New Jersey Superior court in Hinsinger v. Showboat Atlantic City, allowed plaintiff attorney fees to be deducted from an MSA allocation. The Court held that a portion of the attorney’s fees can be taken directly out of a Liability Medicare Set Aside (LMSA) account.
Google Settles Buzz Class Action
The LA Times reported that it will pay $8.5 million to several Internet privacy and policy organizations as part of a class action settlement. The case involved its Buzz social hub, where it was alleged that Google violated privacy rights by automatically adding Buzz to Gmail without proper disclosure.
FDA Resricts Zyprexa Use In Adolescents
In February, 2010, after years of litigation and several settlements, Lilly and the FDA issued a public notice of changes to the Prescribing Information for Zyprexa in adolescents. The changes specifically address the indication for use in adolescents (ages 13-17) for treatment of schizophrenia and bipolar I disorder [manic or mixed episodes].
FDA Osteporosis Drug Warning Contrasts Pior Advisory
Physician's First Watch reports that that "FDA Says Bisphosphonates Might Increase Femoral Fracture Risk, Orders Label Change". The FDA indicated that the reported fractures "may be related to use of bisphosphonates for longer than five years." Consequently, physicians are advised to reevaluate the need for the drugs if their patients have been using them longer than five years.
FDA Adds Warning to Fosamax and Other Bisphosphonates
In light of an increase in the reports of atypical fractures, the FDA added stricter warnings to Bisphosphonates (Osteoporosis Drugs -- including Fosamax, Fosamax Plus D, Actonel, Actonel with Calcium, Boniva, Atelvia, and Reclast)
Kosher First Recall Due to Listeria Monocytogenes
Kosher First Recall Linked to Listeria Monocytogenes contamination.
Joseph Lyon and Associated Press: Discussing Human Tissue Litigation
During the Human Tissue litigation, Joe Lyon was interviewed by the Associated Press and the story gained international attention. The cases were resolved recently for a confidential amount.
Christ Hosptial Settles Fraud Claim, May Lose Medicare and Medicaid
The Health Alliance of Greater Cincinnati and the Christ Hospital Settle Claims for Violating Anti-Kickback Statute and Defrauding Medicare and Medicaid. Now, HHS is considering cutting Christ Hospital from Medicare and Medicaid reimbursement. "Health care providers should make medical decisions based on the needs of their patients, not on the financial interests of physicians or other providers," said Tony West, Assistant Attorney General for the Civil Division of the Department of Justice. "We will not allow hospitals to put profits ahead of sound medical decision-making."
FDA Warns of Risk with Unapproved Use of Malaria Drug Qualaquin
The Lyon Firm is investigating cases related to the unapproved use of Qualaquin. Qualaquin is marketed by Philadelphia based AR Scientific. The FDA approved Qualaquin in August 2005 for treatment of uncomplicated malaria caused by the parasite Plasmodium falciparum, a life threatening infection if left untreated.